bioMérieux (Paris:BIM), a French provider of vitro diagnostics solutions, acquired Applied Maths, a Sint-Martens-Latem, Belgium-based developer of software solutions for the biosciences, in particular for databasing, analysis and interpretation of complex biological data.
The amount of the deal was not disclosed.
Founded in 1992 and led by Koen Janssens, Chief Executive Officer, Applied Maths develops and commercializes software for microbiology applications, including in bacteriology, virology and mycology. Through its ability to manage a wide range of different data types (phenotypic information, molecular PCR, genetic sequences, spectral profiles, whole genome maps, metadata, etc.), BioNumerics software is used in many national and international projects, networks, and critical-mission applications for the integrated analysis of biological data.
Applied Maths has 25 employees and serves more than 2,000 customers worldwide, mainly in Europe and the U.S., including leading public health organizations, research and academic institutions, industrial companies and hospitals.
Initially, the acquisition will enrich and expand the bioMérieux EpiSeq™ service in NGS for the epidemiological monitoring and control of healthcare-associated infections. Taking a more long-term perspective, synergies are foreseen in the field of clinical microbiology, particularly for the optimization of bioMérieux’s data management tools and collection of clinically-relevant bacterial strains, the consolidation of data from different instruments (including the recently-acquired FilmArray®), as well as in industrial microbiology to facilitate the traceability and investigations of epidemics all along the food chain.
Led by Jean-Luc Belingard, Chairman, and Alain Pluquet, Chief Technology Officer, bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. The company is present in more than 150 countries through 42 subsidiaries and a large network of distributors.
In 2014, revenues reached €1,698m with 88% of sales outside of France.